Prescription GLP-1 treatments have been tested in large, long-running clinical trials involving thousands of participants: Semaglutide 2.4 mg (Wegovy) participants lost an average of around 1521% of their body weight over 6872 weeks in the STEP trials Tirzepatide (Mounjaro) the SURMOUNT trials showed average weight loss of 2025% of starting body weight at the highest dose over 72 weeks These results come from rigorously controlled studies with safety monitoring, dose titration, and long-term follow-up
Some people notice reduced cravings within the first few days
Five websites selling them have been taken down
That translates into: Growth in refrigerated warehousing Higher demand for validated cold-chain carriers Continuous temperature monitoring Detailed compliance documentation As pharma freight expands, it increasingly competes for the same temperature-controlled resources that fresh food supply chains rely on
In head-to-head data, yes
Additionally, the Wegovy injection appears to be slightly more effective for weight loss than the Wegovy pill